Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East

Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation for select speciality products of Biocon and be responsible to register, importing, and promoting them in Saudi Arabia and other Middle East countries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ow5JjA
via IFTTT